(R)-(+)-2-[[[3-(morpholinomethyl)-2H-chromen-8-yl]oxy]methyl]morpholine methanesulfonate: A new selective rat 5-hydroxytryptormine(1b) receptor antagonist

Journal of Medicinal Chemistry

Volumn 41, Issue 11, 1998, Pages 1934-1942

  Berg, Stefan ^a   Larsson, Lars Gunnar ^a   Rényi, Lucy ^a   Ross, Svante B ^a   Thorberg, Seth Olof ^a   Thorell Svantesson, Gun ^a  

^a Department of Medicinal Chemistry ^*  (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[[3 (MORPHOLINOMETHYL) 2H CHROMEN 8 YL]OXY]METHYL] MORPHOLINE METHANESULFATE; FENCLONINE; RADIOLIGAND; SEROTONIN 1 ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN REGION; CORPUS STRIATUM; DRUG ACTIVITY; FRONTAL CORTEX; HIPPOCAMPUS; HYPOTHALAMUS; LIGAND BINDING; MOUSE; NONHUMAN; RECEPTOR INTRINSIC ACTIVITY; STRUCTURE ANALYSIS; TURNOVER TIME;

ANIMALS; ANTIDEPRESSIVE AGENTS; AUTORECEPTORS; BEHAVIOR, ANIMAL; BENZOPYRANS; BRAIN; CATTLE; LIGANDS; MORPHOLINES; RATS; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 0032554813     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm970806i     Document Type: Article

References (32)

1. Glennon, R. A.; Dukat, M. Serotonin Receptor Subtypes. In Psychopharmacology: The Fourth Generation of Progress; Bloom, F. E., Kupfer, D. J., Eds.; Raven Press: New York, 1995; pp 415-429.
2. Aghajanian, G. K. Electrophysiology of Serotonin Receptor Subtypes and Signal Transduction Pathways. In Psychopharmacology: The Fourth Generation of Progress; Bloom, F. E., Kupfer, D. J., Eds.; Raven Press: New York 1995; pp 451-460.
3. 1B Binding Sites. Naunyn-Schmiedeberg's Arch. Pharmacol. 1986, 332, 1-7.
4. 1 receptor. Naunyn-Schmiedeberg's Arch. Pharmacol. 1986, 334, 323-326.
5. 1A Selective Agonists. Eur. J. Pharmacol. 1986, 128, 295-298.
6. 1A Agonist Gepirone: Electrophysiological Studies in the Rat Brain. Synapse 1987, 1, 470-480.
7. 1A Agonist 8-OH-DPAT Preferentially Activates Cell Body 5-HT Autoreceptors in the Rat Brain in vivo. Naunyn-Schmiedeberg's Arch. Pharmacol. 1988, 338, 463-471.
8. 1 Agonists Reduce 5-Hydroxytryptamine Release in Rat Hippocampus in vivo as Determined by Brain Microdialysis. Br. J. Pharmacol. 1989, 96, 283-290.
9. 1D Receptor Gene. Trends Pharmacol. Sci. 1992, 13, 152-159.
10. 1-like Receptor in Dog Isolated Saphenous Vein. Br. J. Pharmacol. 1988, 94, 1123-1132.
11. 1D Receptor Antagonist. Br. J. Pharmacol. 1993, 110, 9P.
12. 1 Recognition Sites. J. Receptor Res. 1988, 8, 59-81.
13. 1B Autoreceptor Blocking Properties of the Beta Adrenoceptor Antagonist (-)-Penbutolol. J. Pharmacol. Exp. Ther. 1993, 265, 707-712.
14. 1 Receptor Subtypes in the Rat Brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 1988, 337, 609-620.
15. 1B Receptor of Rat Brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 1991, 341, 1-6.
16. Chatterjee, A.; Roy, D.; Chatterjee, S. K. An Efficient General Method for the Synthesis of Some Intermediates for Heterocyclic Steroids. Synthesis 1981, 449-451.
17. Thorberg, S.-O.; Hall, H.; Åkesson, C.; Svensson, K.; Nilsson, J. L. G. Aminochromans: Potent Agonist at Central Dopamine and Serotonin Receptors. Acta Pharm. Suec. 1987, 24, 169-182.
18. Finholt, A. E.; Bond, A. C.; Schlesinger, H. I. Lithium Aluminum Hydride, Aluminum Hydride and Lithium Gallium Hydride, and Some of their Applications in Organic and Inorganic Chemistry. J. Am. Chem. Soc. 1947, 69, 1199-1203.
19. Yoon, N. M.; Brown, H. C. Selective Reductions. XII Explorations in Some Representative Applications of Aluminum Hydride for Selective Reductions. J. Am. Chem. Soc. 1968, 90, 2927-2938.
20. Kojima, T.; Niigata, K.; Fujikura, T.; Tachikawa, S.; Nozaki, Y.; Kagima, S.; Takahashi, K. Synthesis of (±)-2-[(Inden-7-yloxy)-methyl]morpholine hydrochloride (YM-08054, Indeloxazine Hydrochloride) and its Derivatives with Potential Cerebral-Activating and Antidepressive Properties. Chem. Pharm. Bull. 1985, 33 (9), 3766-3774.
21. Loftus, F. The Synthesis of some 2-Substituted Morpholines. Synth. Commun. 1980, 10 (1), 59-73.
22. 1D Binding Sites in Various Species: Similar Pharmacological Profile in Dog, Monkey, Guinea-Pig and Human Brain Membranes. Naunyn-Schmiedeberg's Arch. Pharmacol. 1992, 346, 243-248.
23. 1F Receptor Messenger RNA in Rodent and Primate Brain. Neuropharmacology 1994, 33, 367-386.
24. 1Dβ receptor antagonist GR 127935. CNS Drug Res. 1996, 2, 415-428.
25. Alcaide, B.; Fernàndez, F. Polycyclic Analogues of Trans-Decalones. Part 6. Synthesis, Optical Resolution and Circular Dichroism of Trans-Transoid-Trans-Perhydrophenanthren-1-one and Trans-Transoid-Trans-Perhydrophenanthren-2-one. J. Chem. Soc., Perkin trans. 1 1983, 1665-1671.
26. Minami, N.; Suzuki, Y. Synthesis of Naphthisoxazole Derivatives. I. Synthesis of 4,5-Dihydronaphth[2,1-d]isoxazole Derivatives. Yakugaku Zasshi 1975, 95, 815-821.
27. Jackson, D. M.; Mohell, N.; Giorgiev, J.; Bengtsson, A.; Larsson, L.-G.; Magnusson, O.; Ross, S. B. Time Course of Bromocriptine Induced Excitation in the Rat: Behavioural and Biochemical Studies. Naunyn-Schmiedeberg's Arch. Pharmacol. 1995, 351, 146-155.
28. 1A Receptor Antagonist, NAD-299. J. Pharmacol. Exp. Ther. 1997, 283, 216-225.
29. 125-Iodocyanopindolol. Eur. J. Pharmacol. 1985, 118, 1-12.
30. 3H]-5 Hydroxytryptamine Binding Site Subtype in Bovine Brain Membranes. J. Neurosci. 1987, 7, 894-903.
31. Ross, S. B. Heterogeneous Binding of Sigma Radioligands in the Rat Brain and Liver: Possible Relationship to Subforms of Cytochrome P-450. Pharmacol. Toxicol 1991, 68, 293-301.
32. 1A Receptor Agonist 8- OH-DPAT. Neuropharmacology 1990, 29, 85-91.